
Opinion|Videos|October 9, 2024 (Updated: October 9, 2024)
Transforming MDD: A Patient's Journey with Rapid-Acting Therapy
A patient suffering from MDD, shares his story and the rapid benefits of patient experience with NMDA-targeted therapy, commenting on the tremendous quality of life benefit.
Advertisement
Episodes in this series

Advertisement
Latest CME
Advertisement
Advertisement
Trending on Psychiatric Times
1
Experience With Xanomeline/Trospium in an Acute Inpatient Setting Treating Individuals With Schizophrenia
2
Home-Based tDCS for Depression: Expanding Access to Neuromodulation Treatment
3
FDA Approves Tauklarify (MK-6240) For Tau Pathology Detection in Alzheimer Disease
4
HLP003, Deuterated Psilocin, as an Adjunctive Therapy for Major Depressive Disorder
5







